The double knockout mdx-utrn−/− model demonstrates a severe DMD phenotype but has limited applicability in therapy development and testing due to utrophin knockout, which will make it difficult to assess its effectiveness in compensating for the missing dystrophin [38]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.